BiotechTube
Home/Breye Therapeutics/Tom Biancardi
TB

Tom Biancardi

Financial Advisor

Breye Therapeutics

Therapeutic Areas

OphthalmologyRetinal Diseases

Breye Therapeutics Pipeline

DrugIndicationPhase
DanegaptideDiabetic RetinopathyPhase 2
Oral P2X7 Receptor AntagonistsDiabetic Retinopathy / Age-related Macular DegenerationPreclinical

Leadership Team at Breye Therapeutics

UM
Ulrik Mouritzen
CEO
PA
Peter Adamson
CSO
KG
Kaare G Rasmussen
Head of CMC
BE
Benedikte el-Bandak Lind
Head of Clinical Operations
MT
Magali Taiel
CMO Consultant
View full Breye Therapeutics profile